Classic hairy cell leukemia Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Jun 2026Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

National Cancer Institute (NCI) — PHASE1, PHASE2

TrialRECRUITING

Jan 2026Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.

Betta Pharmaceuticals Co., Ltd. — PHASE1, PHASE2

TrialRECRUITING

Dec 2025Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

David K Carroll — PHASE1, PHASE2

TrialRECRUITING

Jan 2025Assessment of Disease Burden in Hairy Cell Leukemia

IRCCS Azienda Ospedaliero-Universitaria di Bologna — NA

TrialRECRUITING

Dec 2024Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING

Dec 2024Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management

IRCCS Azienda Ospedaliero-Universitaria di Bologna

TrialRECRUITING

Dec 2024Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management

IRCCS Azienda Ospedaliero-Universitaria di Bologna

TrialRECRUITING

Sep 2024A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

Memorial Sloan Kettering Cancer Center — PHASE2

TrialRECRUITING

Jun 2024Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients

Power Life Sciences Inc.

TrialNOT YET RECRUITING

Mar 2024AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Stanford University — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

3 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance2

LUMOXITI

AstraZeneca Pharmaceuticals LP

OpenContact for detailsApply ↗

Leustatin Injection

R. W. Johnson Pharmaceutical Research Institute

OpenContact for details

Patient Assistance Programs1

Nipent

SuperGen, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

2 FDA-approved

LUMOXITI

(moxetumomab pasudotox-tdfk)Orphan drug

AstraZeneca Pharmaceuticals LP

Approved Sep 2018

Nipent

(pentostatin for injection)Orphan drug

SuperGen, Inc.

Nucleoside Metabolic Inhibitor [EPC]

Approved Oct 1991FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

19 active trials

10Phase 2

3Phase 1

1N/A

3Unknown

1PHASE1, PHASE2

1PHASE2, PHASE3

19Total recruiting

Search clinical trials for Classic hairy cell leukemia →

Recent News & Research

No recent news articles indexed yet for Classic hairy cell leukemia.
Search PubMed for Classic hairy cell leukemia →

Browse all Classic hairy cell leukemia news →

Specialist Network

Top 6 by expertise

Naval Daver, MD, MBBS

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 308 trials

Farhad Ravandi-Kashani, M.D

SWOG Cancer Research Network

📍 HOUSTON, TX

Score 257 trials2 pubs

Robert J Kreitman, M.D., MP

National Cancer Institute (NCI)

📍 OLNEY, MD

Score 1712 trials

Robert J Kreitman, MP

National Cancer Institute LAO

📍 OLNEY, MD

Score 141 trial1 pub

Pier Luigi Zinzani, MD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Score 145 trials

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Score 1213 trials

View all Classic hairy cell leukemia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰